These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
87 related items for PubMed ID: 6338419
1. [Clinical study on the antilipemic effect of tiadenol (Eulip)]. Peduzzi L, Cozzi E. Minerva Med; 1983 Feb 18; 74(6):249-54. PubMed ID: 6338419 [Abstract] [Full Text] [Related]
3. [Evaluation of the effects of tiadenol in various types of dyslipidemia]. Saettone G, Cazzani E, Romanò M, Muzio L. Clin Ter; 1982 May 31; 101(4):387-93. PubMed ID: 7105643 [No Abstract] [Full Text] [Related]
4. [Thiadenol in the short-term treatment of patients with blood lipid disorders]. Di Stefano F, Patane S, Gatto A. Minerva Med; 1980 Mar 03; 71(8):567-74. PubMed ID: 7360386 [Abstract] [Full Text] [Related]
5. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly]. Passeri M, Cocchi C, Ceccato S, Palummeri E, Cucinotta D. G Clin Med; 1979 Jan 03; 60(1):49-64. PubMed ID: 456778 [No Abstract] [Full Text] [Related]
6. [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)]. Rouffy J. Therapie; 1975 Jan 03; 30(6):815-23. PubMed ID: 785682 [No Abstract] [Full Text] [Related]
8. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)]. Cucinotta D, Palummeri E, Ceccato S, Passeri M. G Ital Cardiol; 1977 Jan 03; 7(3):248-64. PubMed ID: 858465 [Abstract] [Full Text] [Related]
9. [Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate]. Nicrosini F, Pasotti C. Clin Ter; 1979 Aug 15; 90(3):241-50. PubMed ID: 553752 [No Abstract] [Full Text] [Related]
10. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk. Velussi M. Nutr Metab Cardiovasc Dis; 2002 Feb 15; 12(1):29-35. PubMed ID: 12125227 [Abstract] [Full Text] [Related]
11. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions]. Vailati G, Montini M, Simonutti M, Nosari I, Pagani G. Clin Ter; 1978 May 31; 85(4):361-73. PubMed ID: 668273 [No Abstract] [Full Text] [Related]
17. [Results of the multicenter controlled study of the hypolipidemic drug polycosanol in Russia]. Nikitin IuP, Slepchenko NV, Gratsianskiĭ NA, Nechaev AS, Syrkin AL, Poltavskaia MG, Sumarokov AV, Revazov AV. Ter Arkh; 2000 May 31; 72(12):7-10. PubMed ID: 11201841 [Abstract] [Full Text] [Related]
19. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A. Int J Clin Pharmacol Res; 1999 May 31; 19(4):105-16. PubMed ID: 10939028 [Abstract] [Full Text] [Related]
20. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia. Castaño G, Fernández L, Mas R, Illnait J, Fernández J, Mesa M, Alvarez E, Lezcay M. Int J Clin Pharmacol Res; 2002 May 31; 22(2):55-66. PubMed ID: 12503776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]